Translational Development Acquisition Corp. (TDACU) Enterprise Value (2023 - 2025)
Translational Development Acquisition's (TDACU) quarterly Enterprise Value came in at -$29787.0 in Q4 2025, up 36.83% on a QoQ basis from -$47150.0 in Q3 2025.
Translational Development Acquisition Corp. (TDACU) Enterprise Value (2023 - 2025) Analysis & Trends
Translational Development Acquisition (TDACU) has 2 years of Enterprise Value data on file, last reported at -$29787.0 in Q4 2025.
- Quarterly Enterprise Value changed N/A year-over-year to -$29787.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$29787.0 (changed N/A YoY) and the FY2025 annual result came in at -$29787.0, changed N/A from the prior year.
- Enterprise Value advanced to -$29787.0 in Q4 2025, from -$47150.0 in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$2021.0 in Q4 2023 to a low of -$47150.0 in Q3 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -29,787.00 |
| Sep 30, 2025 | -47,150.00 |
| Jun 30, 2025 | -35,255.00 |
| Dec 31, 2023 | -2,021.00 |